ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Treatment of Helicobacter pylori infection: Past, present and future

Vasilios Papastergiou; Sotirios D Georgopoulos; Stylianos Karatapanis
World Journal of Gastrointestinal Pathophysiology2014-11-15
11阅读
引用收藏
分享

摘要

Helicobacter pylori(H. pylori) is a major human patho-gen associated with significant morbidity and mortal-ity. However, after decades of efforts, treatment of H. pylori remains a challenge for physicians, as there is no universally effective regimen. Due to the rising prevalence of antimicrobial resistance, mainly to clar-ithromycin, efficacy of standard triple therapies has declined to unacceptably low levels in most parts of the world. Novel regimens, specifically experimented to improve the therapeutic outcome against antibiotic-resistant H. pylori strains, are now recommended as first-line empirical treatment options providing high ef-ficacy(reportedly > 90% in intention to treat analysis) even in high clarithromycin resistance settings. These include the bismuth quadruple, concomitant, sequential and hybrid therapies. Due to the rapid development of quinolone resistance, levofloxacin-based regimens should be reserved as second-line/rescue options. Adjunct use of probiotics has been proposed in order to boost eradication rates and decrease occurrence of treatment-related side effects. Molecular testing meth-ods are currently available for the characterization of H. pylori therapeutic susceptibility, including genotypic detection of macrolide resistance and evaluation of the cytochrome P450 2C19 status known to affect the me-tabolism of proton pump inhibitors. In the future, use of these techniques may allow for culture-free, non-invasive tailoring of therapy for H. pylori infection.

学科与关键词

关键词
Helicobacter pyloriAntibiotic resistanceBismuth-quadrupleConcomitantSequentialProbiotics
相关
加载中…
  • Attempts to enhance the eradication rate of helicobacter pylori infection
    Bang, Chang Seok; Baik, Gwang Ho*WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20(18): 5252-5262.被引 24
  • Prospective Randomized Controlled Trial to Compare Triple Therapy (TT), Sequential Therapy (ST), and Concomitant Therapy (CT) as First-Line Treatments for Helicobacter pylori Infection
    Hussain Ikram; Leong Ang Tiing
  • Emphasizing the importance of successful eradication of Helicobacter pylori on initial treatment
    Zhong, Zishao; Zhan, Bingjie; Xu, Baohui; Gao, Hengjun*American Journal of Cancer Research, 2022, 12(3): 1215-1221.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
World Journal of Gastrointestinal Pathophysiology
发表日期
2014-11-15
卷期
第 04 期
页码
392-399
语言
英文
成果收录
CHINAJOURNAL

作者

  • V

    Vasilios Papastergiou (第一作者)

  • S

    Sotirios D Georgopoulos

查看全部 3 位作者收起作者
  • S

    Stylianos Karatapanis

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417